Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. EQT acquires Candidator
Mandate

EQT acquires Candidator

January 10, 2018 M&A

Vinge has advised Sobro and other owners in conjunction with the sale of all shares in Candidator Holding AB (”Candidator”) to EQT Mid Market Europe (”EQT”).

In connection with the transaction, management will make a significant reinvestment and continue to develop Candidator together with EQT. Candidator is a fast growing IT operation and outsourcing company based in Alingsås and with operations in Stockholm, Gothenburg, Malmö, Bergen and Oslo. The company has approximately 300 employees in Sweden and Norway and a turnover of approximately MSEK 450.

Vinge’s team consisted of Johan Winnerblad, Joacim Rydergård, Filip Brosset, Christina Odengran and Sofie Sundin.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026